Hints and tips:
...The deal is Pfizer’s largest since its 2016 purchase of Medivation for $14.3bn....
...“Voters are gilding the lily about Trump,” says Matt Bennett, a former Clinton aide and co-founder of Third Way, a centre-left think-tank....
...Johnson & Johnson announced in November it had struck a deal to acquire cardiovascular technology group Abiomed for $16.6bn, while Pfizer said in May it had agreed to buy US biotech Biohaven Pharmaceuticals...
...The Wall Street Journal first reported that Pfizer was in advanced talks with GBT....
...In July, Prime Minister Naftali Bennett used a third shot to avert lockdowns as the Delta variant threatened to engulf the country’s medical system when it became clear that the efficacy of Pfizer shots...
...GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Third doses will be available six months after full vaccination only for people who initially received BioNTech/Pfizer jabs....
...James Bullard, president of the St Louis Fed, and one of the longest-serving members of the Federal Open Market Committee, believes it should....
...“Importantly, as part of the agreement, Pfizer will provide the US with 65m paediatric doses should Pfizer’s vaccine be approved for kids under 12, including doses available immediately upon authorisation...
...But rising case rates have alarmed the government of Naftali Bennett, which last month reimposed face mask requirements for indoor gatherings and public transport....
...Scott Gottlieb, a former head of the FDA and a board member at Pfizer, defended the way the administration had handled the issue....
...Additional reporting by James Politi in Washington...
...His follow-up nominations were for Children of a Lesser God, in 1986, and James L Brooks’s Broadcast News in 1987....
...Pfizer, AbbVie and Bristol-Myers Squibb all have blockbuster drugs due to lose exclusivity soon and have recently sealed multibillion-dollar deals....
...The US move followed Canada’s, which last week became the first country to approve Pfizer’s vaccine for under-16s....
...to the CDC “[It is] reasonable to say we are going to immunise children so that we are going to protect the rest of society, but ethically there has to be a benefit for the individual themselves,” said James...
...The EMA is conducting a rolling review of Sputnik V but has yet to authorise it for use across the bloc....
...The Czech Republic could start using Russia’s Sputnik V coronavirus vaccine before it has been approved by the EU’s medicines regulator, prime minister Andrej Babis said on Sunday, as the central European...
...So far, the European Medicines Agency has approved three coronavirus vaccines — made by BioNTech/Pfizer, Moderna, and Oxford/AstraZeneca — for use in the bloc....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Coronavirus digest The US will purchase 500m Pfizer-made vaccines to donate to other countries, Joe Biden will announce today....
...The three countries are in talks with Pfizer and Moderna about the factories....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
International Edition